JPWO2024262349A1 - - Google Patents
Info
- Publication number
- JPWO2024262349A1 JPWO2024262349A1 JP2025527894A JP2025527894A JPWO2024262349A1 JP WO2024262349 A1 JPWO2024262349 A1 JP WO2024262349A1 JP 2025527894 A JP2025527894 A JP 2025527894A JP 2025527894 A JP2025527894 A JP 2025527894A JP WO2024262349 A1 JPWO2024262349 A1 JP WO2024262349A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/12—Cyclic peptides with only normal peptide bonds in the ring
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Polymers & Plastics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Food Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023099982 | 2023-06-19 | ||
| PCT/JP2024/020914 WO2024262349A1 (ja) | 2023-06-19 | 2024-06-07 | 認知機能の低下抑制又は改善用組成物、及び、β－セクレターゼ阻害用組成物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPWO2024262349A1 true JPWO2024262349A1 (https=) | 2024-12-26 |
Family
ID=93935282
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025527894A Pending JPWO2024262349A1 (https=) | 2023-06-19 | 2024-06-07 |
Country Status (3)
| Country | Link |
|---|---|
| JP (1) | JPWO2024262349A1 (https=) |
| TW (1) | TW202515596A (https=) |
| WO (1) | WO2024262349A1 (https=) |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7202279B1 (en) * | 1998-02-11 | 2007-04-10 | Georgetown University | Cyclic dipeptides and azetidinone compounds and their use in treating CNS injury and neurodegenerative disorders |
| WO2015194070A1 (ja) * | 2014-06-20 | 2015-12-23 | サントリーホールディングス株式会社 | 環状ジペプチド高含有組成物 |
| JP6684277B2 (ja) * | 2015-07-01 | 2020-04-22 | サントリーホールディングス株式会社 | レニン−アンジオテンシン系抑制用組成物 |
| WO2017010133A1 (ja) * | 2015-07-16 | 2017-01-19 | サントリーホールディングス株式会社 | 動植物由来ペプチド含有血清カルノシン分解酵素阻害用組成物 |
| WO2017010537A1 (ja) * | 2015-07-16 | 2017-01-19 | サントリーホールディングス株式会社 | 環状ジペプチド含有血清カルノシン分解酵素阻害用組成物 |
| JP6719475B2 (ja) * | 2015-09-04 | 2020-07-08 | サントリーホールディングス株式会社 | ウレアーゼ活性阻害剤 |
| WO2017115438A1 (ja) * | 2015-12-28 | 2017-07-06 | サントリーホールディングス株式会社 | ビールテイスト飲料 |
| WO2017119481A1 (ja) * | 2016-01-08 | 2017-07-13 | サントリーホールディングス株式会社 | 環状ジペプチド含有神経性疾患予防用組成物 |
| WO2017119476A1 (ja) * | 2016-01-08 | 2017-07-13 | サントリーホールディングス株式会社 | 神経性疾患予防用組成物 |
| JP6598412B1 (ja) * | 2019-06-04 | 2019-10-30 | ゼライス株式会社 | 認知機能改善用食品 |
| WO2022131026A1 (en) * | 2020-12-18 | 2022-06-23 | Suntory Holdings Limited | Use of cyclic dipeptides in production of agent for inhibiting decline in cognitive function or ameliorating cognitive dysfunction |
| AU2022420239A1 (en) * | 2021-12-23 | 2024-07-11 | Suntory Holdings Limited | Composition for suppressing or ameliorating cognitive function decline |
-
2024
- 2024-06-07 WO PCT/JP2024/020914 patent/WO2024262349A1/ja not_active Ceased
- 2024-06-07 JP JP2025527894A patent/JPWO2024262349A1/ja active Pending
- 2024-06-18 TW TW113122523A patent/TW202515596A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TW202515596A (zh) | 2025-04-16 |
| WO2024262349A1 (ja) | 2024-12-26 |